Hormonoradiothérapie adjuvante concomitante des cancers du sein : état de l'art

This publication has 45 references indexed in Scilit:

• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer
  Cancer, 2003
• Letrozole (Femara®) sensitises breast cancer cells to gamma irradiation
  International Journal of Radiation Oncology*Biology*Physics, 2003
• Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial
  The Lancet, 2002
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Anastrozole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma
  Cancer, 2001
• Double-blind, randomised, multicentre endocrine trial comparing two letrozole doses, in postmenopausal breast cancer patients
  European Journal Of Cancer, 1999
• Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin
  New England Journal of Medicine, 1997
• Radiotherapy-Related Lung Fibrosis Enhanced by Tamoxifen
  JNCI Journal of the National Cancer Institute, 1996
• Transforming Growth Factor β in Tissue Fibrosis
  New England Journal of Medicine, 1994
• Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture.
  Proceedings of the National Academy of Sciences, 1986